The American journal of medicine, 2011-09, Vol.124 (9), p.793-799
2011
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Stroke Prevention in Atrial Fibrillation: Current Status and Near-Future Directions
- Ist Teil von
- The American journal of medicine, 2011-09, Vol.124 (9), p.793-799
- Ort / Verlag
- New York, NY: Elsevier Inc
- Erscheinungsjahr
- 2011
- Quelle
- Access via ScienceDirect (Elsevier)
- Beschreibungen/Notizen
- Abstract Prevention of atrial fibrillation-related stroke is an important part of atrial fibrillation management. However, stroke risk is not homogeneous and varies with associated morbidities and risk factors. Risk stratification schemes have been developed that categorize patients' stroke risk into classes based on a combination of risk factors. According to the calculated level of risk, guidelines recommend patients with atrial fibrillation receive antithrombotic therapy either as a vitamin K antagonist or aspirin. Despite recommendations, however, many patients with atrial fibrillation do not receive adequate thromboprophylaxis. We will discuss some of the underlying reasons, in part related to the drawbacks associated with vitamin K antagonists. These highlight the need for new anticoagulants in atrial fibrillation. The novel oral anticoagulants in development may overcome some of the limitations of vitamin K antagonists and address their underuse and safety concerns.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0002-9343eISSN: 1555-7162DOI: 10.1016/j.amjmed.2011.03.013Titel-ID: cdi_proquest_miscellaneous_884846189
- Format
- –
- Schlagworte
- Administration, Oral, Aged, Aged, 80 and over, Antagonist drugs, Anticoagulants, Antithrombins - adverse effects, Antithrombins - pharmacokinetics, Antithrombins - therapeutic use, Antithrombotic therapy, Aspirin - adverse effects, Aspirin - pharmacokinetics, Aspirin - therapeutic use, Atrial fibrillation, Atrial Fibrillation - blood, Atrial Fibrillation - complications, Atrial Fibrillation - drug therapy, Biological and medical sciences, Cardiac arrhythmia, Contraindications, Disease prevention, Drug Interactions, Drug-Related Side Effects and Adverse Reactions, Drugs, Investigational - adverse effects, Drugs, Investigational - pharmacokinetics, Drugs, Investigational - therapeutic use, Factor Xa Inhibitors, Fibrinolytic Agents - adverse effects, Fibrinolytic Agents - pharmacokinetics, Fibrinolytic Agents - therapeutic use, General aspects, Guideline Adherence, Humans, Internal Medicine, Medical sciences, Neurology, Prevention and actions, Public health. Hygiene, Public health. Hygiene-occupational medicine, Randomized Controlled Trials as Topic, Risk Factors, Stroke, Stroke - prevention & control, Thromboembolism, Thrombosis, Vascular diseases and vascular malformations of the nervous system, Vitamin K - antagonists & inhibitors